News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Bernard Sagaert

Bernard Sagaert is interim CEO at etherna.

Articles by Bernard Sagaert

Ribosome as part of an biological cell constructing messenger rna molecules - 3d illustration | Image Credit: ©Christoph Burgstedt - Stock.adobe.com

Delivering on the Potential of mRNA Therapeutics

ByDavid Ricketts ,Nevin Witman ,Phil Challis ,Senne Dillen ,Bernard Sagaert

April 15th 2023

The complexity of the RNA production process creates challenges.

Latest Updated Articles

Delivering on the Potential of mRNA Therapeutics
Published: April 15th 2023 | Updated:

Trending on Pharmaceutical Technology

How the Critical Medicines Act Aims to Optimize European Pharma Competitiveness and Resilience

© 2025 MJH Life Sciences^®

All rights reserved.